All News

Cancer — and its treatments — can feel like a grueling race, but I’m using frequent follow-ups and an excellent care team to stay ahead of the game.

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

Although patients with cancer may feel both grateful and grief towards their bodies, one expert emphasizes how important seeking support from a professional can be throughout this process.

When my wife was going through cancer treatments, she sometimes would color my artwork as a distraction. Here’s an activity I made for other survivors, now that it’s the year of the rabbit.

The FDA recently approved a combination treatment for patients with previously treated metastatic colorectal cancer with HER2-positive disease determined by biomarker testing.

A phase 2 study will investigate the efficacy of darovasertib for patients with uveal melanoma and whether the drug can potentially result in lower radiation doses or fewer eye removal surgeries.

Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

I exercised and ate healthy, yet still received a cancer diagnosis, leaving me wondering, “why me?”

We surveyed the CURE® audience about how cancer impacted their relationship with their hair. Here’s what they had to say.

Patients with advanced HCC who progressed after treatment with immunotherapy may have a survival benefit when treated with second-line Lenvima.

Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.

Zolbetuximab plus mFOLFOX6 lengthened the time to progression for patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma.

The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.

Patients with HER2-low gastric cancer tended to have distinct characteristics compared to those with HER2-negative or -positive disease, warranting more research into this group, research found.

Skin cancer can also occur in the nail area and may be associated with HPV, it may not be as common for it to result from a cut experienced during a manicure, one expert explained.

My friend, Kevin, was like a brother to me, so I cursed cancer when he died, yet am thankful for the time that we had together.

From Tennis star Chris Evert’s cancer-free status to Duran Duran’s Andy Taylor talking about his prostate cancer, here’s what’s happening in the oncology space this week.

Lytgobi was approved for pretreated cholangiocarcinoma in September, and updated study findings support the drug’s continued approval.

The Food and Drug Administration approved Brukinsa for patients with chronic lymphocytic leukemia or small lymphocytic leukemia.

The FDA approved Tukysa plus Herceptin for previously treated patients with HER2-positive metastatic colorectal cancer.

Patients undergoing surgery for gynecologic cancer may benefit from acupressure, acupuncture and other relaxation techniques regarding pain relief and a reduction in anxiety.

My family is scattered throughout the country, so I often rely on friends to lend a helping hand.

An oncolytic virus engineered to kill cancer cells was administered to a patient with pancreatic ductal adenocarcinoma as part of a phase 2b trial.

The trial is evaluating the safety and efficacy of AVB-001 patients with relapsed refractory ovarian cancer.

Patients with operable non-small cell lung cancer who were treated with an anti-PD-1 monoclonal antibody plus a doublet chemotherapy regiment did not experience cancer recurrence or new symptom onset during follow-up in a recent study.

Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.

Last month, I learned that the treatment for my metastatic breast cancer stopped working, but was thrilled to learn about Enhertu — a new drug for a new subset of patients with breast cancer — as the next line of therapy.